Hysteroscopy, the Window into the Uterine Cavity by Naor-Revel, Shani et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Hysteroscopy, the Window into 
the Uterine Cavity
Shani Naor-Revel, Ruth Goldstone and Ariel Revel
Abstract
Hysteroscopy, is a technique by which we can look into the uterine cavity  
entering through the cervix and is today the most applied minimally invasive 
technique in Gynecology. Indications for hysteroscopy include infertility investiga-
tion, abnormal uterine bleeding, and evaluation of suspicious sonographic findings. 
Nowadays we approach the uterus via vaginoscopy with no anesthetic. Once inside 
the uterus, we remove polyps or stringless IUD and take a biopsy. These procedures 
are often referred as “see and treat”. Operative hysteroscopy under GA or sometimes 
cervical block, uses larger instruments to resect myomas, cut a septum (metro-
plasty) or separate intrauterine adhesions (Asherman’s). As Glycine is no more used 
in hysteroscopy it has become quite a safe procedure. Use of disposable scopes will 
enable this tool to be part of every gynecologic clinic.
Keywords: hysteroscopy, infertility, uterine bleeding, menorrhagia, metrorrhagia, 
intrauterine device, septate uterus, asherman’s uterine adhesion, fibroids, 
endometrium, polyps, see and treat
1. Introduction
In 1950, doctors could expect medical knowledge to double every 50 years. By 
2020, it will take just 73 days. How’s a doctor supposed to keep up? [1]. Writing a 
chapter to a textbook is thus a challenge. Even if we succeed in being up to date by 
the time this chapter is published it might already be obsolete. The reader should 
thus read the chapter as an introduction and follow up on the topics read. As car-
rying out hysteroscopies requires manual training, we hope that the gynecologist 
reading our chapter will gain theoretical understanding along with his or her train-
ing first on a simulator before performing this procedure on real patients. We think 
that a gynecology resident should perform 100 diagnostic hysteroscopy procedures 
before attempting an operative one.
2. History of hysteroscopy
“Hysteroscopy” comes from the Greek terms hysteros meaning uterus and scopy 
meaning to look. Hysteroscopy enabled visualization of a narrow and dark space, 
which was difficult until the mid-nineteenth century. Endoscopy was invented by 
Bozzini in 1805. The first successful hysteroscopy however was performed 65 years 
later by Pantaleoni when he investigated the uterus of a 60-year-old patient com-
plaining of postmenopausal bleeding. Bozzini detected a polyp in the uterus which 
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he cauterized with silver nitrate. Bozzini died at 35 years of age from typhoid fever, 
and his attempts to improve the light conductor ended. Table 1 mentions some of 
the pioneers that have contributed to the hysteroscope.
For distending the uterine cavity for operative hysteroscopy normal saline is 
used nowadays as it is significantly less dangerous than glycine when fluid loss 
occurs. Hysteroscopy today represents 200 years of significant innovations in 
instrumentation, new clinical applications for existing instruments, and continual 
modification of techniques, all aiming at observing, diagnosing, and treating 
pathologic conditions of the uterine cavity.
3. Indications
Indications for diagnostic hysteroscopy include many conditions where knowl-
edge about the endometrial cavity is relevant to patient care but the scope of this 
chapter has not been able to go into depth for every indication. In Table 2 we list 
the most common indications for the procedure as well as which tools are required 
and how long we recommend for such a procedure. This may help the team com-
municate with each other and referring physicians and the patients, where should 
the procedure be scheduled and how long it should take and which equipment is 
required for the procedure.
3.1 Menstrual cycle bleeding
Bleeding at menstruation (menorrhagia) or in between them (metrorrhagia). 
Postmenopausal bleeding should include a blind biopsy. Patients with bleeding 
under hormonal replacement therapy should be examined. A frequent referral are 
patients on continuous Tamoxifen therapy [2]. Bleeding under medical therapy 
requires a pathological sampling to exclude malignancy. Pipelle ® sampling has 
100% sensitivity and specificity to detect malignant cells [3].
Heavy menstrual bleeding is a significant health problem in pre and perimeno-
pausal women. If no pathology is diagnosed using diagnostic hysteroscopy and 
biopsy, patients should be counseled about treatment which could be hormonal and 
non-hormonal. As medical therapy is not always successful, Endometrial ablation 
may be an alternative to hysterectomy that preserves the uterus. Many techniques 
have been developed to ablate the endometrium. First-generation techniques 
require visualization of the uterus with a hysteroscope during the procedure. 
Nitze 1877 Magnifying lense
Heineberg 1914 Parallel chanel, continuous flow
Rubin 1925 CO2 insufflation
Mickulicz-Radecki 1927 electrocoagulation
Vulmiere 1952 Fiber optics
Harold Horace Hopkins and Storz 1959 Rod lens optic
Marleschki 1965 contact hysteroscope
Edström and Fernström 1970 Dextran
Hamou 1980 Glycine
Bettochi 1997 Office scope
Table 1. 
Milestones in the development of the hysteroscope.
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Second- and third-generation techniques are quicker than previous approaches 
because they do not require hysteroscopic visualization during the procedure. 
Decision as to visual or blind procedure is based on the skills of the surgeon and on 
the size of the uterus. Results and patient satisfaction appear to be similar [4].
3.2 Postpartum or post miscarriage/induced abortion bleeding
Postpartum bleeding raises a suspicion of placental remains. There also may 
be bleeding due to retained products of conception following an abortion either 
spontaneous or induced for medical reasons.
3.3 IUD related
Common referral to hysteroscopy is to remove an IUD. In cases where the strings 
are not apparent referral to hysteroscopy is preferable to the patient than attempting 
blind instrument IUD extraction.
3.4 Suspected malignancy by sonography
Often the indication is sonographic findings such as suspicion of submucosal 
uterine fibroids, adenomyosis, endometrial cancer. It should be stressed that follow-
ing removal of a polyp and diagnosis of malignancy it is obligatory to plan hyster-
ectomy even if the rest of the cavity seemed normal in hysteroscopy. In an Israeli 
study, residual complex atypical hyperplasia (CAH) or endometrial cancer (EC) 
was present in 89% of the hysterectomy specimens, mostly (55.6%) as multifocal 
lesions [5].
3.5 Asherman’s
Hysteroscopy is currently considered the gold standard diagnostic and therapeu-











bleeding under medical therapy
Out Pipelle ® 3
10.2 Products of conception In Grasper/loop 10–30





Out Pipelle ® 3
10.5 Asherman’s In Needle tip 10–50
10.6 Fibroid/ metroplasty In Loop 5–50
10.7 Primary/secondary infertility and 
assessing tubal patency
Out Bubbles sometimes 
Pipelle ®
5
10.8 Habitual abortions Out Pipelle ® 3
10.9 Niche In Loop 5–15
Table 2. 
Inpatient or outpatient indications for hysteroscopy, device and time needed to complete the procedure.
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including preoperative, intraoperative, and postoperative therapeutic measures, 
however, are warranted owing to the complexity of the syndrome.
3.6 Fibroid, septate uterus
Hysteroscopic removal of endometrial polyps suspected on ultrasound in 
women prior to IUI and IVF may improve the clinical pregnancy rate compared to 
simple diagnostic hysteroscopy [6].
3.7 Primary/secondary infertility; assessing tubal patency
Hysteroscopy should be part of evaluation of primary and secondary infertility 
[6]. The performer should investigate and describe the uterine shape to exclude a 
septate uterus or other Mullerian abnormalities of the uterus, the endometrium to 
exclude intrauterine synechia (adhesions, Asherman’s) and atrophy. Moreover an 
attempt to pass bubbles via the tubal ostia determines tubal patency [7].
3.8 Habitual abortions/recurrent pregnancy loss (RPL)
When a woman has 3 or more consecutive spontaneous abortions we recom-
mend evaluation which includes a diagnostic procedure to evaluate the uterine 
cavity. Office hysteroscopy, is the easiest and most informative tool to investigate 
possible intrauterine abnormalities such as septate uterus or intrauterine adhesions 
or a polyp in patients with RPL or recurrent implantation failure (RIF).
3.9 Niche
Control examination of the uterine cavity after operations on the uterus such 
as cesarean to see the niche, curettage to evaluate whether there are remains, 
Asherman’s to evaluate the reappearance of adhesions. Following metroplasty for 
septate uterus it is good practice to evaluate the cavity by hysteroscopy to confirm if 
postoperatively the uterine cavity is fit for pregnancy. In some cases, a reoperation 
is required to complete cutting an extensive septum. Also, following myomectomy 
it is recommended to repeat hysteroscopy to judge whether there are any remnants 
of the myoma and that no postoperative adhesions have formed.
4. The hysteroscopy team
The hysteroscopy clinic enables patients to undergo the procedure in the office 
setting. Patients can continue their day plans without need to cancel pleasure activi-
ties or work. The team involves administrative, nursing and the physician. It is quite 
important for the team to work in a concerted way so that the patient arrives at the 
correct time and the correct equipment is ready for the procedure.
4.1 The administrative assistant
An experienced secretary is an important player for a well-orchestrated team 
to work coherently. When a patient calls in for an appointment, you should 
transfer the call to a dedicated secretary and follow a planned call question-
naire. The most important question is asking about the date of the patient’s last 
menstrual period. In premenopausal women, hysteroscopy should be performed 
between days 7–11 following the beginning of the menstrual period. This achieves 
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a certainty about our patient not being pregnant and the lining of the uterus is 
thin, in order to see a good view of the uterus. The patient is advised to eat before 
coming to the clinic to reduce the complication of a low blood sugar or weakness 
after the procedure.
In case of doubt the patient is required to carry out βhCG in the blood before 
coming the clinic. if this was not performed, a urinary pregnancy test to ensure 
βhCG is negative. Moreover, it is easier to introduce the scope during menstruation 
as the cervix is slightly relaxed.
4.2 Nursing
Dedicated and professional nursing is an integral part of hysteroscopy. We find 
it quite efficient to have three nurses working with the physician hysteroscopist in 
the diagnostic and in the see and treat hysteroscopy clinic. One nurse sits with the 
patient and explains to her the procedure and prepares her for the signing of the 
informed consent with the physician and to offer the patient oral analgesia before 
the procedure.
The second nurse will be assisting the physician during the procedure making 
sure that the equipment is sterile, connecting the light cable and the normal saline 
to the scope as well as handing over surgical tools such as grasper or scissors to 
perform a ‘see and treat’ procedure and to ensure the wellbeing of the patient. The 
patient will be seated and covered by the nurse and at the end of the procedure the 
nurse will ensure that the patient safely descends from the gynecological chair and 
is able to go and get dressed on her own.
The third nurse oversees sterilization of the hysteroscope optics and sheaths.
It is recommended for a busy clinic to have quite a few both diagnostic and 
‘see and treat’ scopes. We usually schedule a dozen patients per clinic morning, 
sterilization must thus be carried out in parallel to performing the procedures so 
that unprepared equipment is not the bottleneck of the clinic. It is recommended 
that the hysteroscopy clinic nurse attends courses given to physicians or to nurses 
about hysteroscopy, its indications, contraindications and how the procedures are 
performed. Teaching a new nurse should be done by an experienced nurse to ensure 
that safety and efficacy are carried out. Only after such training should a new nurse 
assist a hysteroscopy clinic. In the UK, a nurse hysteroscopist performs diagnostic 
procedures [8]. In Israel and to the best of our knowledge in mainland Europe and 
North America however, only physicians are licensed to carry out invasive proce-
dures on live patients.
Before signing the informed consent, the nurse briefs the patient on the hystero-
scopic procedure. Main points explained are the following:
• The hysteroscope is inserted through the vagina and cervix into the uterus. It is 
very fine and ordinarily a speculum is not used.
• Liquid solution is passed through the hysteroscope throughout the procedure, 
to expand the uterus and to clear away any blood or mucus.
• The physician will gently insert the hysteroscope which has a light source and 
can also introduce small tools through a side port. This will enable her to have 
also a treatment such as removing a polyp or an intrauterine device.
• The nurse explains to the patient that she must read the consent form before 
sitting with the doctor and any questions regarding the consent form she will 
be able to receive an explanation before the procedure from the doctor.
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4.3 The Gynecologic surgeon
A hysteroscopist is usually a certified gynecologic surgeon. There is mounting 
evidence in the surgical literature to support the use of skilled labs outside of the 
operating room for resident training and indeed simulation is the key point for 
an appropriate surgical learning [9]. It is necessary to improve the quality of the 
simulators by enhancing or introducing tactile feedback [10].
The physician must carry out three main duties prior to beginning hysteroscopy.
Firstly, review the patient’s medical, gynecological, and obstetrical history in 
general and the reason for referral to the procedure.
Secondly, explain the indication to the patient and thus discuss expectations. For 
example, if it is to evaluate the endometrial cavity prior to embryo transfer, or to 
remove an IUD. Another example is suspicion of postpartum residual placental tis-
sue where it should be clear that we will need to schedule an operative procedure as 
the amount of tissue to be removed exceeds possibility by see and treat equipment.
Thirdly the physician is responsible to rule out an ongoing pregnancy. In case of 
any suspicion, the patient performs a urinary or blood hCG.
It is imperative that the doctor detail and explain the very rare complications of 
a procedure prior to starting surgery. The physician should make sure the patient 
understands that there are rare complications in less than 1% of cases. Anesthesia if 
used, has rare complications. Intrauterine infection is a contraindication for hyster-
oscopy. Perforation of the uterus can occur and should be diagnosed immediately 
by the gynecologist. In such complication the patient will be evaluated to rule out 
possible damage to her bowel, blood vessel or bladder. Intrauterine adhesions may 
occur following operative surgery, especially for large lesion such as a myomectomy. 
With the use of normal saline as distending medium there are no adverse reaction to 
the distention media as was seen sometimes with Glycine or Dextran. After review-
ing such these rare complications, the physician and patient are now ready to sign 
an informed consent form.
5. The equipment
Equipment that is needed to perform diagnostic hysteroscopy includes the 
fibreoptic scope, a light cable, and the camera. The camera is connected to a screen. 
It is recommended to have a camera and a printer to capture and then insert pic-
tures into your operative report. Through an operating channel mechanical tools 
can be inserted to carry out a ‘see and treat’ procedure in an outpatient setting 
[11]. Moreover, the advent of new technologies is further changing the approach of 
outpatient hysteroscopic surgery. Some procedures that in the past required cervi-
cal dilatation to introduce the resectoscope can currently be perfomed using a thin 
hysteroscope [12].
For all purposes we use a 1.9 (2.8 with sheath) millimeter rigid hysteroscope. For 
the see and treat the diameter is 4.2 millimeter with the scope of 2.9 millimeter. We 
find those scopes are well tolerated even by nulliparous or postmenopausal patients.
5.1 Distension of the uterine cavity
Currently we use normal saline for all our hysteroscopic procedures. The use of 
Glycine is dangerous as it may cause hyponatremia [13]. For the diagnostic procedure 
the one- or three-liter bag of normal saline flows using gravity is used. It is however 
easier to use a balloon handpump as sometimes the patient has blood clots in the uterine 
cavity that need to be flushed out so the gynecologist can see the endometrial cavity.
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5.2 Single use scopes
Clinics commonly perform hysteroscopy with multiple use equipment. Recently 
single use hysteroscopes have been developed (Neoscope or Lina operascope). This 
may be a suitable option at a gynecologist office where few procedures are performed.
5.3 Hysteroscopy tissue removal systems
Hysteroscopic tissue removal systems (Truclear®, Myosure® or IBS®) may offer 
an advantage in successful removal of pathology and shorten total operation time.
6. Hysteroscopic method
For purpose of clarity, we will describe how to perform outpatient and inpatient 
procedures, separately.
6.1 Outpatient hysteroscopy
In order to overcome the sensation of pain caused by speculum and tennacu-
lum among patients undergoing office hysteroscopy the vaginoscopy approach 
(no touch) was first proposed by Bettocchi [14]. The method uses no insertion 
of speculum nor any instruments to grasp the uterine cervix. The performer uses 
vocal analgesia. This means that you keep talking to your patient while performing 
the procedure and not necessarily showing her the instruments that you use. The 
patient is encouraged to look at the screen and be part of the procedure. In a ran-
domized trial, oral analgesia was shown to reduce pain [15].
The patient is covered in lithotomy position with her legs comfortably in stirrups. 
There is no need for scrubbing nor washing. Following digital gentle separation of 
the major labia and gently inserting the tip of the hysteroscope, the performers eyes 
are then reverted to the screen while filling the vagina with normal saline.
At this point the cervix should be located. Usually, the uterine cervix will be 
found in the posterior part of the vagina, you then direct the scope to the opening of 
the cervix and gently land on it with your scope in order to enter. The rigid hystero-
scope needs to gently enter into the cervical canal. The scope has a 30 degree angle 
and therefore while going through the cervical canal the opening of the canal should 
be seen at 6 o’clock and gently slide along the cervical canal until the inner os of the 
uterine cavity is observed. In a retroverted uterus this is the opposite, the hands 
should be reversed and therefore the opening of the cervix will be seen at 12 o’clock. 
When the uterus is very introverted you could use your hand to put a little suprapu-
bic pressure on the uterus in order to straighten it. You can use one hand at this step 
in order to enter the uterus and if needed ask a nurse to apply the suprapubic pres-
sure or even the patient herself. The entry to the uterine cavity should be performed 
very slowly and carefully watching in order to prevent pain and in order to avoid the 
possibility of entering forcefully and causing a perforation. Throughout the proce-
dure the patient should be relaxed. The physician should perform all actions slowly 
using the left hand to hold the camera in a fixed position while the scope with a 30 
degree angle is moved along the longitudinal axis, observing the right wall then the 
anterior wall, then the left wall and then the posterior wall. All these should be done 
by rotating the attachment of the light cable to the hysteroscope, Taking pictures is 
recommended.
The whole procedure is performed very slowly., retracting the scope looking on 
the exit at the lower anterior wall of the uterus. This is especially relevant in patients 
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who had a previous cesarean section, in order to observe if there is a niche. Looking 
at the cervical canal can give some information about the possibility of a polyp. The 
instrument is then removed from the vagina. The whole procedure should take no 
longer than one minute.
6.2 See and treat
Performance of diagnostic and operative procedures for gynecological condi-
tions in the consultation room setting is becoming increasingly commonplace to 
reduce risks of general anesthetic, decrease healthcare costs and increase conve-
nience for both patient and gynecologist. Diagnostic hysteroscopy is performed 
using the required instrument (e.g. scissors or grasper) on standby inside the 
working canal. Intrauterine contraceptive device (IUD) removal or its fragments 
is a common referral. Use of small diameter hysteroscopes and resectoscopes allow 
these procedures to be performed as a single stage “see-and-treat” hysteroscopy in 
the comfort and safety of an office-based setting.
6.3 Operative
Hysteroscopic surgery has become the standard of care to treat benign intra-
uterine disease in pre-menopausal and even postmenopausal women. The various 
hysteroscopic procedures have been shown as safe and highly effective to treat 
lesions such as submucous myomas, endometrial polyps, uterine septa and intra-
cavitary adhesions.
Operative hysteroscopy is performed in the OR and thus offers advantages 
and disadvantages. Advantages include the possibility to remove large pathologies 
from the uterine wall. The operative hysteroscope is inserted following dilatation 
of the uterine cervix to hegar dilator 10-10.5 under general anesthesia. 
There are 3 parts to the operative procedure. First the dilatation of the cervix. 
This might turn out to be the risky part and indeed most complications occur at 
this step [6]. The second part deals with the pathology, whether it be using the 
loop to resect a polyp or type 0 submucosal fibroid [pedunculated fibroids with-
out any intramural extension]. It is more difficult to remove a type 1 [submucosal 
with minor intramural] fibroid. Type 2 fibroids [mostly intramural, the angle 
with the endometrium is>90°] should not be removed by hysteroscopic surgery.
7. Analgesia
With new hysteroscopes, it is possible not only to examine the cervical canal and 
uterine cavity but also to perform biopsies or treat benign diseases in a relatively 
short time, without any premedication for anesthesia. This is because the sensory 
innervation of the uterus mainly regards the myometrium, while the endometrium 
and the fibrous tissue of septa and synechiae are almost insensative [16]. Preventing 
pain is very important.The pain is caused by distending the uterus and mostly in the 
cervical canal.
7.1 Analgetics
The use of rectal indomethacin, ropivacaine or levobupicavaine diluted in the 
saline distension medium, the use of multimodal local anesthesia as well as the use 
of premedication by means of diclofenac potassium or tramadol are all effective 
methods to reduce pain. There is a lack of consensus on the choice of analgesia for 
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outpatient hysteroscopy, with a recent meta-analysis and systematic review sug-
gesting oral nonsteroidal anti-inflammatory drugs and transcutaneous electrical 
nerve stimulation (TENS) for pain relief [17].
7.2 Preparation of the cervix with vaginal misoprostol
Giving low-dose (25 mcg) Misoprostol before the procedure may soften the cervix 
sufficiently to allow an easier and more successful test. This medication has been tested 
before intrauterine procedures including hysteroscopy and, in some patients, it has 
been shown to be beneficial. Cervical priming facilitated hysteroscopy by dilating the 
cervix, allowing for easier entry and reducing procedural time. Administration of a 
cervical preparation, however, increased the risk of adverse effects, namely genital 
tract bleeding, abdominal pain/cramping and gastrointestinal disturbance [18].
7.3 Distraction techniques
Non-pharmacological options of pain relief at outpatient hysteroscopy include 
music, hypnosis, adjusting the temperature and pressure of distension medium, 
stretching of the uterus with a full bladder and electricity via TENS. What we 
usually do is to have a cheerful conversation with the patient, and we suggest con-
trolled breathing in order to relax the body. It is helpful to suggest to the patient 
to watch the screen as we explain what we see. Since this chapter is written during 
the covid-19 pandemic we do not allow the partner to join the patient. Somewhat 
surprisingly we are under the impression that this has resulted in reducing 
patient stress.
7.4 Virtual reality
Virtual reality (VR) was suggested as a distraction technique for non-pharma-
cological pain relief. It is a computer-generated representation of an immersive 
environment viewed through a headset. VR is effective in reducing pain and anxiety 
during outpatient hysteroscopy [19].
8. Contraindications
Hysteroscopy is contraindicated in patients with Pelvic infection, Pregnancy, 
Cervical cancer or Heavy uterine bleeding. If the contraindications to hysteroscopy 
are observed, complications should be rare.
9. The hysteroscopy reports
The medical report represents one of the most critical steps not only from a 
legal, medical point of view but also for the patient and other health profession-
als. It should first include the description of the instruments used: hysteroscope, 
optics, distension medium, and any mechanical or energy tools. Subsequently, 
the technique used for access to the cervical canal should be reported, plus the 
morphology of the cervical canal and the uterine cavity should be carefully 
described. We report the visualization of both the tubal Ostia and whether they 
appear patent by passing bubbles. Findings such as polyps, fibroids, adhesions, 
or a septum should be described in detail. This includes location, size, vascu-
larization, and severity. At the end of the report, your patient should receive 
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recommendations. If surgery is required it should be stated and a referral for 
surgery added. In patients undergoing infertility treatment it should be added 
when the exam is normal that the uterus appears to be compatible for pregnancy. 
This will indicate to the patient and the infertility team that it is recommended to 
proceed with IVF or other methods used.
Before discharge, all information written in the letter should be explained to the 
patient and questions should be answered in detail so that the patient has all the 
information required for further treatment.
10. Complications
Morbidity and even death have been reported after hysteroscopic interventions 
[20, 21].
10.1 Adhesions resulting in defective endometrial receptivity
Hysteroscopic resection of a polyp, fibroid or placental pregnancy products is 
frequently performed to increase IVF success rates. Moreover, a septate uterus may 
hinder pregnancy following embryo transfer. Hysteroscopic adhesiolysis is the gold 
standard intervention to treat intrauterine adhesions.
Nevertheless, intrauterine procedures by themselves may cause defective endo-
metrial receptivity [22].
We thus carry out the procedure with paramount prudence so as not to harm 
normal endometrium nor cause adhesions. In patients who have children, it is 
crucial to know before surgery if the patient has completed her family plans. For 
example, if a patient in her 40’s has perimenopausal menorrhagia is undergo-
ing hysteroscopic polypectomy the operation would be carried out in different 
mode whether she wants to preserve her fertility potential or not. This should be 
described in her informed consent. Some have claimed that endometrial thickness 
is narrower following polypectomy. We have looked into this and have found that 
our pregnancy rates were higher despite a mild postoperative decrease in endome-
trial thickness [23].
10.2 Perforation of the uterine wall
The most common complication of hysteroscopy is uterine perforation 
(approximately 1%) which can occur with a blunt instrument (uterine sound, 
dilator, curette, hysteroscope) or during the use of an energy source such as elec-
trosurgery (i.e., inappropriate use of electrodes), with a possible injury of the sur-
rounding organs (bladder, bowel, vessel) resulting in catastrophic consequences. 
An alternative to the utilization of a thermal energy source during hysteroscopic 
surgery is the use of mechanical energy such as scissors or intrauterine morcel-
lator (IUM) to treat benign pathologies such as polyps, myomas, and retained 
products of conception.
10.3 Infection
The prevalence of infections following in-office hysteroscopy is low (0.06%) 
[24]. routine antibiotic prophylaxis is thus unnecessary before hysteroscopy. 
Patients should be counseled that if they have fever following an hysteroscopic 
procedure they should contact your office or out of hours go to the gynecology 
emergency room.
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10.4 Bleeding
In most patients, we performed the procedure on the last days of the menstrual 
cycle therefore bleeding is still present before and after hysteroscopy. The patient 
should be informed that mild bleeding is normal after the procedure nevertheless 
if severe bleeding ensues or continues the patient should contact the clinic or out of 
hours go to the emergency room to exclude a serious complication from the hys-
teroscopic procedure. In diagnostic hysteroscopy we perform a procedure using the 
new vaginoscopic approach, therefore in most cases there is no bleeding at all from 
the procedure itself. In inpatient hysteroscopy. anesthesia we use the tenaculum 
and Hagars to dilate the cervix, therefore bleeding results mostly from the surgical 
intervention. Also following the removal of fibroids or polyps some bleeding is 
expected, although this should stop within a few hours following the procedure. In 
some cases removing a large fibroid leaves a large area of exposed blood vessels and 
attempts should be made during the procedure to obtain hemostasis using coagu-
lation. If bleeding continues the physician may introduce an intrauterine Foley 
catheter and inflate it, which should be removed an hour later. In most cases, this 
stops the bleeding and patient is discharged home only after evaluation that there is 
no substantial bleeding after surgery. 
11. Cost
In Israel, most procedures are performed in the HMO setting and therefore 
it is free for our patients. According to the Israeli ministry of health price list the 
reimbursement for a diagnostic hysteroscopy is 606 NIS whereas, for a surgical 
procedure the reimbursement is 1,104 NIS.
In USA, the cost of a hysteroscopy ranges from $750-$3,500. The cost depends 
on the extent of the procedure. For instance, a diagnostic-only procedure is much 
less than one involving surgery. The cost may be higher for a more extensive proce-
dure which includes surgery in the hospital and general anaesthesia. Costs for these 
extensive procedures can be up to $7,000. Some US health insurance carriers will 
cover a hysteroscopy, at least partially. 
 In an Italian paper [25], total hospital costs for polypectomy with all systems 
were significantly less expensive in an office setting compared with same-day 
surgery in the hospital setting (p = .0001).
12. Conclusions
Hysteroscopy is an essential part of the gynecologist’s toolbox. Nowadays, 
hysteroscopy is the gold standard for the diagnosis and treatment of intrauterine 
pathologies as it represents a safe and minimally invasive procedure that allows 
the visualization of the entire uterine cavity. It is an inexpensive however valuable 
method. Cervical preparation before examination with vaginal misoprostol reduces 
pain during outpatient hysteroscopy and can be offered particularly to nulliparous 
or postmenopausal patients. Hysteroscopy requires certain skills and experience 
and is not exempt from complications, especially in unexperienced hands. The 
report should describe the method used to perform the procedure and then the 
relevant findings. This includes the shape of uterine cavity, the endometrium, 
and the right and left ostia. In infertile patients, describe whether bubbles travel 
through the fallopian tube openings. Gynecologist should be familiar with this tool 
for better evaluation and treatment of their patients.
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